Reference is made to the stock exchange announcements made by Inify Laboratories AB (the "Company") on 16 December 2024 regarding the allocation of 30,202,366 new shares in a private placement […]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]

Inify Laboratories, a unique laboratory service that performs cancer diagnostics within pathology, has entered into an agreement with the region of Västmanland in Sweden on a pilot project with the […]

 STOCKHOLM – 7 January 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company“) on 16 December 2024 regarding the successful private placement […]

Reference is made to the stock exchange announcement published today, 16 December 2024, regarding the successful private placement of 30,202,366 new shares (the “Private Placement”) in Inify Laboratories AB (publ) […]